Suc-Leu-Leu-Val-Tyr-AMC
CAS: 94367-21-2
Ref. 3D-FS110535
2mg | 211,00 € | ||
5mg | 343,00 € | ||
10mg | 503,00 € | ||
50mg | 1.033,00 € | ||
100mg | 1.458,00 € |
Información del producto
- Chymotrypsin Substrate III
- Fluorogenic
- N-succinyl-leu-leu-val-tyr 7-amido-4-*methylcouma
- Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide
- Llvy-mca
- N-Succinyl-leu-leu-val-tyr-7-amido-4-methylcoumarin
- Sllvt-mca
- Suc-leu-leu-val-tyr-7-amino-4-methylcoumarin
- Suc-leu-leu-val-tyr-mca
- Suc-llvy-mca
- Ver más sinónimos
- L-Tyrosinamide, N-(3-carboxy-1-oxopropyl)-L-leucyl-L-leucyl-L-valyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-
- N-(3-carboxypropanoyl)leucylleucyl-L-valyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-tyrosinamide
Suc-Leu-Leu-Val-Tyr-AMC is a cyclin D2 inhibitor that binds to the proteasome and inhibits its function. It has been shown to be useful for the treatment of cancerous tissues as it inhibits the production of prostaglandin J2, which is involved in the progression of cancer cells. Suc-Leu-Leu-Val-Tyr-AMC has also been shown to have antioxidant properties and can inhibit oxidative injury. This drug may be used to prevent or treat various diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, diabetes mellitus type II, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and septic shock.
Propiedades químicas
Consulta técnica sobre: 3D-FS110535 Suc-Leu-Leu-Val-Tyr-AMC
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.